AHL Interviews Jay Lichter, Bringing NewCos to San Diego
American Healthcare Leader (AHL) interviewed Jay Lichter, Ph.D., to talk to him about why he built a different kind of incubator to start companies in San Diego. About ten years ago, when Jay was a...
View ArticleHow To Name Your Life Science Startup
In 2014, a promising young immuno-oncology startup named Alinos was incorporated. It had a great team and great technology. Unfortunately, the crew hadn’t yet established the website. When it came time...
View ArticleFortis Therapeutics Receives FDA Clearance of Two IND Applications for Novel...
SAN DIEGO, November 6, 2018 – Fortis Therapeutics, Inc., an immuno-oncology biotech developing a novel antibody-drug conjugate (ADC) against CD46, today announced the U.S. Food and Drug Administration...
View ArticleClik here to view.
That’s a wrap on 2018…hello 2019!
2018 was a great year for COI startups. Here were our company milestones, funding successes, honors and more. Money raises It seems 2018 was Synthorx’s year. With its new president and CEO, Laura...
View ArticleAvalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari...
GSK to obtain transglutaminase 2 small molecule program for celiac disease SAN DIEGO, September 11, 2019 – Avalon Ventures today announced that it entered into a definitive agreement with...
View ArticleCOI Pharmaceuticals Announces Acquisition of Calporta by Merck
SAN DIEGO, November 13, 2019 – COI Pharmaceuticals, the Community Of Innovation established by Avalon Ventures, today announced the acquisition of Calporta Therapeutics, Inc. by Merck, known as MSD...
View ArticleSanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5...
Proprietary immuno-oncology (IO) platform synergistic with Sanofi’s existing therapeutic platforms Lead asset THOR-707 (“not-alpha” IL-2) being explored across multiple solid tumor types alone and in...
View ArticleeConsult solution company AristaMD secures $18 million in Series B funding
MemorialCare Innovation Fund and Cigna Ventures Lead Financing for Best-in-Class AristaMD eConsult Platform SAN DIEGO – March 31, 2020 – AristaMD, a digital health company that provides a proprietary...
View ArticleeConsult Solution Company AristaMD Adds Ascension Ventures and .406 Ventures...
SAN DIEGO, July 14, 2020 – AristaMD, a leading digital health company that provides proprietary eConsult solutions that connect primary care providers (PCPs) with timely, documented specialist...
View ArticleAvelas Announces Top-Line Data Showing Pegloprastide (AVB-620) Can...
Use of pegloprastide, a fluorescent cancer marker, during surgery correctly identified cancer in up to 75% of patients who would have otherwise been candidates for a repeat (re-excision) surgery...
View Article